Daunorubicin and cytarabine liposome Intravenous and Sandostatin LAR
Determining the interaction of Daunorubicin and cytarabine liposome Intravenous and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin and cytarabine liposome Intravenous-Sandostatin LAR Depot
- Daunorubicin and cytarabine liposome Intravenous-Sandostatin LAR Depot injection
- Daunorubicin and cytarabine liposome Intravenous-Sani-Supp
- Daunorubicin and cytarabine liposome Intravenous-Sani-Supp rectal
- Daunorubicin and cytarabine liposome Intravenous-Sansert
- Daunorubicin and cytarabine liposome Intravenous-Santyl
- Sandostatin LAR-Daunorubicin citrate
- Sandostatin LAR-Daunorubicin citrate liposome Intravenous
- Sandostatin LAR-Daunorubicin hydrochloride
- Sandostatin LAR-Daunorubicin Intravenous
- Sandostatin LAR-DaunoXome
- Sandostatin LAR-Daurismo